Vesicular monoamine transporter 1
Protein involved in neurotransmitter transport
The vesicular monoamine transporter 1 (VMAT1) is a protein that in humans is encoded by the SLC18A1 gene. VMAT1 is a type of transporter protein that is responsible for packaging monoamine neurotransmitters into synaptic vesicles in neurons. This process is crucial for the proper functioning of synaptic transmission in the nervous system.

Function[edit]
VMAT1 is primarily involved in the transport of monoamines such as serotonin, dopamine, norepinephrine, and epinephrine from the cytosol of the neuron into synaptic vesicles. This transport is essential for the storage and subsequent release of these neurotransmitters into the synaptic cleft during neurotransmission.
Mechanism[edit]
VMAT1 operates through a mechanism known as secondary active transport. This process utilizes the proton gradient across the vesicular membrane to drive the uptake of monoamines into the vesicles. The proton gradient is maintained by a proton pump that actively transports protons into the vesicle, creating an electrochemical gradient. VMAT1 uses this gradient to transport monoamines against their concentration gradient into the vesicle.
Clinical significance[edit]
Alterations in VMAT1 function have been implicated in various neurological disorders and psychiatric conditions. For example, changes in VMAT1 activity can affect the levels of neurotransmitters available for release, potentially contributing to conditions such as depression, schizophrenia, and bipolar disorder.
Genetics[edit]
The SLC18A1 gene, located on chromosome 8, encodes the VMAT1 protein. Variations in this gene can lead to differences in VMAT1 function and expression, which may influence an individual's susceptibility to certain neurological and psychiatric disorders.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian